12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Lyrica pregabalin: Phase III discontinued

Pfizer stopped the double-blind, international Phase III A0081244 trial to treat neuropathic pain associated with HIV neuropathy after a planned interim analysis of 246 patients by the study's DMC showed that improvements in neuropathic pain symptoms were "virtually identical" between the Lyrica and placebo...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >